Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

134 ARTÍCULOS , VIENDO DEL 16 AL 30

Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection

Risacher SL, Saykin AJ.

Annu Rev Clin Psychol. 2013;9:621-48. doi: 10.1146/annurev-clinpsy-050212-185535. Epub 2013 Jan 7.

Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes

Delvaux E, Bentley K, Stubbs V, Sabbagh M, Coleman PD.

Neurobiol Aging. 2013 Jun;34(6):1680-6. doi: 10.1016/j.neurobiolaging.2012.12.004. Epub 2013 Jan 5.

Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers

Kosicek M, Hecimovic S.

Int J Mol Sci. 2013 Jan 10;14(1):1310-22. doi: 10.3390/ijms14011310.

Plasma proteomics for the identification of Alzheimer disease

Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):337-42. doi: 10.1097/WAD.0b013e31827b60d2.

Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol

Mangialasche F, Westman E, Kivipelto M, Muehlboeck JS, Cecchetti R, Baglioni M, Tarducci R, Gobbi G, Floridi P, Soininen H, Kłoszewska I, Tsolaki M, Vellas B, Spenger C, Lovestone S, Wahlund LO, Simmons A, Mecocci P; AddNeuroMed consortium.

J Intern Med. 2013 Jun;273(6):602-21. doi: 10.1111/joim.12037. Epub 2013 Feb 28.

A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease

Peters KR, Lynn Beattie B, Feldman HH, Illes J.

Prog Neurobiol. 2013 Nov;110:114-23. doi: 10.1016/j.pneurobio.2012.12.001. Epub 2013 Jan 21.

State of the science: use of biomarkers and imaging in diagnosis and management of Alzheimer disease

Fraller DB.

J Neurosci Nurs. 2013 Apr;45(2):63-70. doi: 10.1097/JNN.0b013e3182829024.

Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 2: new immune paradigm

Fulop T, Lacombe G, Cunnane S, Le Page A, Dupuis G, Frost EH, Bourgade-Navarro K, Goldeck D, Larbi A, Pawelec G.

Discov Med. 2013 Jan;15(80):33-42.

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB.

Neurology. 2013 Mar 12;80(11):1048-56. doi: 10.1212/WNL.0b013e3182872830. Epub 2013 Feb 6.

Alzheimer disease biomarkers and insights into mild cognitive impairment

Knopman DS.

Neurology. 2013 Mar 12;80(11):978-80. doi: 10.1212/WNL.0b013e31828728ac. Epub 2013 Feb 6.

Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography

Rosenberg PB, Wong DF, Edell SL, Ross JS, Joshi AD, Brašić JR, Zhou Y, Raymont V, Kumar A, Ravert HT, Dannals RF, Pontecorvo MJ, Skovronsky DM, Lyketsos CG.

Am J Geriatr Psychiatry. 2013 Mar;21(3):272-8. doi: 10.1016/j.jagp.2012.11.016.

Genetic study of neurexin and neuroligin genes in Alzheimer's disease

Martinez-Mir A, González-Pérez A, Gayán J, Antúnez C, Marín J, Boada M, Lopez-Arrieta JM, Fernández E, Ramírez-Lorca R, Sáez ME, Ruiz A, Scholl FG, Real LM.

J Alzheimers Dis. 2013;35(2):403-12. doi: 10.3233/JAD-122257.

Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease

Perneczky R, Guo LH, Kagerbauer SM, Werle L, Kurz A, Martin J, Alexopoulos P.

Transl Psychiatry. 2013 Feb 19;3(2):e227. doi: 10.1038/tp.2013.11.

Imaging epigenetics in Alzheimer's disease

Lista S, Garaci FG, Toschi N, Hampel H.

Curr Pharm Des. 2013;19(36):6393-415. doi: 10.2174/13816128113199990370.

Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI

Vos SJ, van Rossum IA, Verhey F, Knol DL, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Frisoni GB, Froelich L, Nobili F, van der Flier W, Blennow K, Wolz R, Scheltens P, Visser PJ.

Neurology. 2013 Mar 19;80(12):1124-32. doi: 10.1212/WNL.0b013e318288690c. Epub 2013 Feb 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias